Home Cart 0 Sign in  

[ CAS No. 202590-98-5 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
Chemical Structure| 202590-98-5
Chemical Structure| 202590-98-5
Structure of 202590-98-5 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 202590-98-5 ]

Related Doc. of [ 202590-98-5 ]

Alternatived Products of [ 202590-98-5 ]

Product Details of [ 202590-98-5 ]

CAS No. :202590-98-5 MDL No. :MFCD26960949
Formula : C25H22ClN5O2S Boiling Point : -
Linear Structure Formula :- InChI Key :GNMUEVRJHCWKTO-FQEVSTJZSA-N
M.W : 491.99 Pubchem ID :9936746
Synonyms :
MK-8628;OTX-015;(−)-OTX015;HY-15743
Chemical Name :(S)-2-(4-(4-Chlorophenyl)-2,3,9-trimethyl-6H-thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepin-6-yl)-N-(4-hydroxyphenyl)acetamide

Calculated chemistry of [ 202590-98-5 ]

Physicochemical Properties

Num. heavy atoms : 34
Num. arom. heavy atoms : 22
Fraction Csp3 : 0.2
Num. rotatable bonds : 5
Num. H-bond acceptors : 5.0
Num. H-bond donors : 2.0
Molar Refractivity : 139.12
TPSA : 120.64 Ų

Pharmacokinetics

GI absorption : Low
BBB permeant : No
P-gp substrate : Yes
CYP1A2 inhibitor : No
CYP2C19 inhibitor : Yes
CYP2C9 inhibitor : Yes
CYP2D6 inhibitor : No
CYP3A4 inhibitor : Yes
Log Kp (skin permeation) : -6.11 cm/s

Lipophilicity

Log Po/w (iLOGP) : 3.01
Log Po/w (XLOGP3) : 4.5
Log Po/w (WLOGP) : 4.64
Log Po/w (MLOGP) : 3.16
Log Po/w (SILICOS-IT) : 5.98
Consensus Log Po/w : 4.26

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 0.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -5.87
Solubility : 0.000657 mg/ml ; 0.00000134 mol/l
Class : Moderately soluble
Log S (Ali) : -6.75
Solubility : 0.0000866 mg/ml ; 0.000000176 mol/l
Class : Poorly soluble
Log S (SILICOS-IT) : -8.65
Solubility : 0.0000011 mg/ml ; 0.0000000022 mol/l
Class : Poorly soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 1.0 alert
Leadlikeness : 2.0
Synthetic accessibility : 4.53

Safety of [ 202590-98-5 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P305+P351+P338 UN#:N/A
Hazard Statements:H302-H315-H319-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 202590-98-5 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Downstream synthetic route of [ 202590-98-5 ]

[ 202590-98-5 ] Synthesis Path-Downstream   1~1

  • 1
  • [ 202590-98-5 ]
  • [ 165963-71-3 ]
  • [ 2688070-50-8 ]
YieldReaction ConditionsOperation in experiment
81.05% With potassium carbonate In acetonitrile at 70℃; for 17h; 1D.3 Step 1: Synthesis of tert-butyl (S)-(26-(4-(2-(4-(4-chlorophenyl)-2,3,9-trimethyl-6H- thieno[3,2-f][l,2,4]triazolo[4,3-a][l,4] diazepin-6-yl)acetamido)phenoxy)-3,6,9,12,15,18,21,24- octaoxahexacosyl)carbamate General procedure: To a solution of (S)-2-(4-(4-chlorophenyl)-2,3,9-trimethyl-6H-thieno[3,2-f][l,2,4]triazolo[4,3- a][l,4]diazepin-6-yl)-N-(4-hydroxyphenyl)acetamide (150.00 mg, 0.31 mmol, 1.00 equiv) in MeCN (4.00 mL) was added tert-butyl N-(26-bromo-3, 6, 9, 12, 15,18,21,24-octaoxahexacosan-l-yl) carbamate (175.77 mg, 0.31 mmol, 1.00 equiv) and K2CO3 (84.27 mg, 0.61 mmol, 2.00 equiv). Then the reaction mixture was stirred at 60 degrees C for 17 h. The solid was filtrated out and the filtration was concentrated. The residue was purified by silica gel column chromatography, eluted with DCM: MeOH = 10: 1. Tert-butyl (S)-(26-(4-(2-(4-(4-chlorophenyl)-2,3,9-trimethyl-6H-thieno[3,2-f][l,2,4]triazolo[4,3- a][l,4]diazepin-6-yl)acetamido)phenoxy)-3,6,9,12,15,18,21,24-octaoxahexacosyl)carbamate ( 350.00 mg, quantitative yield) as white solid. LCMS: mass calcd. For C48H67CIN6O12S: 986.42, found: 1009.60 [M+Na]+.
Same Skeleton Products
Historical Records